Effect of latent human immunodeficiency virus infection on cell surface phenotype

Journal of Virology

Volumn 76, Issue 4, 2002, Pages 1673-1681

  Brooks, David G ^a   Zack, Jerome A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD45 ANTIGEN; FAS ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS PROTEIN; ZIDOVUDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LATENT VIRUS INFECTION; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOCYTE; THYMOCYTE; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD4; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; DOWN-REGULATION; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MICE; MICE, SCID; PHENOTYPE; T-LYMPHOCYTES; THYMUS GLAND; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0036147830     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.4.1673-1681.2002     Document Type: Article

References (40)

1. Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain
2. The SCID-hu mouse as a model for HIV-1 infection
3. In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline
4. Expression of CD25 defines peripheral blood mononuclear cells with productive versus latent HIV infection
5. Generation of HIV latency during thymopoiesis
6. + cell model of chronic infection
7. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef
8. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
9. Re-emergence of HIV after stopping therapy
10. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy
11. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection
12. Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines
13. Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy
14. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
15. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
16. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
17. Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy
18. Population biology of HIV-1 infection: Viral and CD4+ T cell demographics and dynamics in lymphatic tissues
19. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
20. In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus
21. Mechanism of HIV-1 localization in CD4-negative thymocytes: Differentiation from a CD4-positive precursor allows productive infection
22. Induction of MHC class I expression on immature thymocytes in HIV-1-infected SCID-hu Thy/Liv mice: Evidence of indirect mechanisms
23. Altered expression of CD4, CD54, CD62L, and CCR5 in primary lymphocytes productively infected with the human immunodeficiency virus
24. + lymphocytes by human immunodeficiency virus type 1 in vivo
25. Induction of HIV-1 replication by allogeneic stimulation
26. + T cells are infected in human immunodeficiency virus type 1-infected individuals
27. Decay characteristics of HIV-1-infected compartments during combination therapy
28. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
29. Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1
30. The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy
31. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein
32. Nef triggers a transcriptional program in T cells imitating a single-signal T cell activation and inducing HIV virulence mediators
33. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes
34. Human immunodeficiency virus type-1 tat enhances interleukin-2 promoter activity through synergism with phorbol ester and calcium-mediated activation of the NF-AT cis-regulatory motif
35. Viral dynamics in human immunodeficiency virus type 1 infection
36. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells
37. Transient renewal of thymopoiesis in HIV-infected human thymic implants following antiviral therapy
38. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
39. Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells
40. Genetic characterization of rebounding HIV-1 after cessation of highly active anti-retroviral therapy